Skip to main content
. 2020 Oct 22;65(2):301–310. doi: 10.1007/s00484-020-02032-6

Table 6.

Comparison of Δ (post-treatment–pre-treatment) gains per group

Treatment group p value
Group 1 Group 2
Mean ± SD Median(min-max) Mean ± SD Median(min-max)
Flexion 6.67 ± 15.37 0 (− 10, 70) 13.44 ± 17.57 10 (0–70) 0.021μ
Abduction 6.33 ± 12.99 0 (− 10, 60) 15.67 ± 21.73 10 (− 10, 80) 0.018μ
Internal rotation 3.10 ± 10.05 0 (0–50) 11.78 ± 17.62 0 (− 20, 60) 0.008μ
External rotation 6.44 ± 10.20 0 (− 20, 40) 15.11 ± 16.74 10 (− 20, 70) 0.01μ
Resting VAS − 1 ± 1.58 0 (− 6, 1) − 2.18 ± 2.15 − 2 (− 6, 0) 0.008μ
Sleep VAS − 2.82 ± 2.50 − 2 (− 10, 0) − 3.98 ± 2.70 − 4 (− 10, 0) 0.034μ
Movement VAS − 2.50 ± 2.46 − 2 (− 9, 2) − 3.56 ± 2.29 − 4 (− 10, 0) 0.028μ
QuickDASH − 14.73 ± 13.16 − 11.4 (− 51, 3.7) − 24.4 ± 17.84 − 15.9 (− 75, − 2.2) 0.007μ
SF36 Vitality 2.33 ± 9.80 0 (− 45, 20) 14.22 ± 21.56 5 (− 20, 65) 0.028μ
SF36 Physical Function 9.55 ± 10.92 11.1 (− 11.1, 44.4) 20.38 ± 18.95 16.6 (0, 61.1) 0.001§
SF36 Pain 23 ± 23.79 22.5 (− 42.5, 67.5) 34.61 ± 23.85 32.5 (0, 90) 0.043μ
SF36 General Health 0.51 ± 5.46 0 (− 15, 15) 6.78 ± 18.16 0 (− 30, 65) 0.026μ
SF36 Physical Role Limitation 19.78 ± 37.69 0 (− 50, 100) 40.56 ± 47.76 25 (− 100, 100) 0.01μ
SF36 Emotional Role Limitation 9.63 ± 25.25 0 (0, 100) 27.41 ± 44.54 0 (0–100) 0.068μ
SF36 Social Function 4.72 ± 14.42 0 (− 12.5, 75) 17.78 ± 25.35 0 (0–75) 0.003μ
SF36 Mental Health 1.13 ± 10.06 0 (− 35, 24) 11.56 ± 19.22 0 (− 8, 60) 0.081μ
Hand grip strength (Jamar) 0.71 ± 3.19 0 (− 8, 10) 1.68 ± 3.28 2 (− 3, 13) 0.002μ

Δ gain: Post-treatment–pre-treatment measurement

§t test in independent groups

μMann-Whitney U test

Group 1 patients receiving physical therapy and exercises for treatment

Group 2 patients receiving physical therapy, balneotherapy, and exercises for treatment

VAS Visual Analogue Scale

QuickDASH Quick Disabilities of the Arm, Shoulder and Hand

SF36 Short Form-36